Quadrant Capital Group’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-7,647
Closed -$760K 2465
2026
Q1
$760K Sell
7,647
-34
-0.4% -$4.43K 0.02% 691
2025
Q4
$934K Sell
7,681
-2
-0% -$251 0.03% 591
2025
Q3
$862K Buy
7,683
+71
+0.9% +$8.31K 0.03% 581
2025
Q2
$1.02M Buy
7,612
+184
+2% +$20.2K 0.04% 473
2025
Q1
$500K Buy
7,428
+7,134
+2,427% +$491K 0.02% 738
2024
Q4
$18.3K Buy
294
+265
+914% +$24.7K ﹤0.01% 1929
2024
Q3
$4.55K Buy
29
+4
+16% +$616 ﹤0.01% 2341
2024
Q2
$3.77K Buy
25
+3
+14% +$360 ﹤0.01% 2362
2024
Q1
$1.63K Hold
22
﹤0.01% 2538
2023
Q4
$1.74K Sell
22
-1
-4% -$60 ﹤0.01% 2497
2023
Q3
$1.26K Sell
23
-158
-87% -$11.4K ﹤0.01% 2459
2023
Q2
$15.2K Buy
181
+33
+22% +$2.53K ﹤0.01% 1837
2023
Q1
$11.2K Buy
148
+114
+335% +$7.88K ﹤0.01% 1982
2022
Q4
$2.1K Sell
34
-17
-33% -$904 ﹤0.01% 2397
2022
Q3
$2K Buy
+51
New +$2.22K ﹤0.01% 2433
2021
Q4
Sell
-18
Closed -$1K 2696
2021
Q3
$1K Buy
+18
New +$550 ﹤0.01% 2397

Other funds holding TMDX

Quadrant Capital Group's TMDX Position: Q2 2026 in Review

Quadrant Capital Group sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 7,647 shares — an estimated $760K sold.

Quadrant Capital Group first reported a position in TMDX in Q3 2021 and held it in 16 quarters. The position peaked at $1.02M in Q2 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Quadrant Capital Group reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
  • Quadrant Capital Group sold 7,647 Transmedics shares in Q2 2026, an estimated $760K.
  • Quadrant Capital Group first reported a position in Transmedics in Q3 2021 and held it in 16 quarters.
  • Quadrant Capital Group's Transmedics position peaked at $1.02M in Q2 2025.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.